MediWound MDWD
NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT

MediWound (MDWD) Other financing activities (2013 - 2026)

MediWound (MDWD) posted Other financing activities of $767000.0 for Q2 2026, up 12683.33% on a QoQ basis from $6000.0 in Q4 2025, and down 8.47% year-over-year from $838000.0 in Q2 2025.

Analysis

MediWound (MDWD) Other financing activities (2013 - 2026) Analysis & Trends

MediWound has reported Other financing activities for 11 years, with the latest figure at $767000.0 in Q2 2026.

  • On a quarterly basis, Other financing activities fell 8.47% year-over-year to $767000.0 in Q2 2026; TTM through Jun 2026 was $4.4 million, a 183.86% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 200.0% from the prior year.
  • Other financing activities was $767000.0 for Q2 2026 at MediWound, up from $6000.0 in the prior quarter.
  • The five-year high for Other financing activities was $25.2 million in Q1 2023, with the low at -$24.9 million in Q4 2023.
  • Average Other financing activities over 5 years is $2.4 million, with a median of $767000.0 recorded in 2026.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities slumped 1092.79% in 2023, then soared 654.95% in 2025.
  • Over 5 years, Other financing activities stood at $2.5 million in 2022, then plunged by 1092.79% to -$24.9 million in 2023, then jumped by 102.41% to $600000.0 in 2024, then sank by 99.0% to $6000.0 in 2025, then soared by 12683.33% to $767000.0 in 2026.
  • The last three Other financing activities figures came in at $767000.0 (Q2 2026), $6000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 MediWound 156.09 Mn 120.75 Mn 337,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 767,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 2.79 Mn
Jun 30, 2025 838,000.00
Sep 30, 2024 600,000.00
Jun 30, 2024 111,000.00
Mar 31, 2024 499,000.00
Dec 31, 2023 -24.91 Mn
Jun 30, 2023 -248,000.00
Mar 31, 2023 25.16 Mn
Dec 31, 2022 2.51 Mn
Sep 30, 2022 12.05 Mn
Mar 31, 2022 10.42 Mn
Dec 31, 2021 -4.00 Mn
Jun 30, 2021 -4,000.00
Dec 31, 2017 -136,000.00
Sep 30, 2017 5,000.00
Jun 30, 2017 2,000.00
Dec 31, 2016 5,000.00
Sep 30, 2016 2,000.00